Sea lice (Lepeophtheirus salmonis and Caligus elongatus) are ectoparasitic copepods that infest farmed Atlantic salmon. They are the most significant welfare and production challenge in salmon aquaculture, affecting hundreds of millions of fish annually across Norway, Scotland, Chile, and Canada.
Scale: Norway produces 1.5M tonnes salmon/year | Sea lice cost Norwegian industry $500M+/year | Treatment frequency: some farms treat 3-4x/year | Each treatment event affects 100,000-500,000 fish | ~400M farmed salmon are treated for sea lice annually worldwide
Sea Lice Welfare Impacts
Sea lice cause direct welfare harm through:
Skin damage: Lice attach to salmon skin and scrape away mucus, scales, and epidermis — creating open wounds. Heavy infestations cause extensive lesions, exposing underlying tissue to infection.
Pain and itch response: Salmon with sea lice show abnormal behaviors consistent with irritation — increased gill flapping, flashing (scraping against cage walls), lethargy, and reduced feeding. These are behavioral indicators of nociception and discomfort.
Stress immunosuppression: Chronic sea lice infestation elevates cortisol, suppresses immune function, and makes salmon more susceptible to secondary infections.
Mortality: Heavy infestations, particularly in juvenile salmon, can cause significant mortality through osmotic disruption when lice damage enough skin surface area.
Treatment Welfare Costs
Treatment Dilemma: Sea lice treatments themselves cause significant welfare harm. Chemical bath treatments (azamethiphos, hydrogen peroxide) require crowding fish into well boats and exposing them to chemicals at concentrations lethal to lice — causing stress, disorientation, and in poorly calibrated treatments, mortality. Freshwater treatment (effective against marine lice) causes osmotic stress. Mechanical removal (hydrolicer, thermolicer) uses water jets or warm water to dislodge lice — causing stress and fin damage. The cumulative welfare cost of treatment across all treated fish may exceed the cost of the lice themselves.
Non-Medicinal Innovations
The industry is investing heavily in non-medicinal approaches to reduce treatment frequency:
Cleaner fish: Wrasse and lumpfish eat lice directly from salmon — when stocked at appropriate densities. Welfare concern: wrasse and lumpfish themselves have welfare needs that are poorly addressed on most farms.
Deep lights and feeding: Keeping salmon deep (>10m) during peak lice settlement periods; sea lice larvae are phototactic and surface-oriented.
Snorkel barriers: Physical barriers preventing lice-carrying surface water from reaching fish
Laser systems (Stingray): Automated laser delousing systems target individual lice with pulses — reduces chemical treatments but causes disturbance to fish during operation
Closed-containment aquaculture (land-based recirculating systems) eliminates sea lice entirely by removing contact with wild sea lice populations. RAS (Recirculating Aquaculture Systems) systems are growing but remain more expensive than sea cage production. Their welfare advantages include: no sea lice; controlled water quality; no escapes; and elimination of treatment welfare costs.